washington biotechnology inc., cro, in vivo, in vitro, drug screening models, inflammation, arthritis, bacterial infection, cancer, xenograft, diabetes, inflammatory bowel disease, cell culture, cytokine analysis, custom antibodies, monoclonal antibody, us fda registration, usda, pharmacokinetics, toxicity, safety, immunogenicity

drug discovery made easier with washington biotechnology's comprehensive, flexible, cost-effective and speedy in vivo and in vitro customized solutions - drug and vaccine studies, drug development, in vivo inflammation models, in vivo cancer xenograft models, custom antibodies